When was Capra Biosciences founded?

Capra Biosciences was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is Capra Biosciences located?

Capra Biosciences is headquartered in Manassas, United States.

Who is the current CEO of Capra Biosciences?

Elizabeth Onderko of Capra Biosciences.

How many employees does Capra Biosciences have?

As of Apr 30, 2026, the latest employee count at Capra Biosciences is 23.

Is Capra Biosciences a funded company?

Capra Biosciences is a funded company, having raised a total of $5.75M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 17, 2021.

When was the latest funding round of Capra Biosciences?

Capra Biosciences' latest funding was a $***** Series A round on Nov 28, 2023, with participation from 0 investor.

Where does Capra Biosciences rank among its competitors?

Capra Biosciences ranks 26th amongst 152 active competitors, of which 50 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Co-reactive, which secured $7.75M in Jan, 2026.

Who are the top competitors of Capra Biosciences?

Capra Biosciences' top competitors include LanzaTech, Manus Bio and Calyxia. Among them, Co-reactive secured the most recent funding round in January, 2026.

Capra Biosciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of bioreactor technology creating bio-based chemicals from waste materials. The company specializes in producing hydrophobic chemicals using biofilms and solvent extraction. Products include ingredients for consumers and industry. The company focuses on engineering non-model organisms to produce chemicals.

Website: www.caprabiosciences.com
Social
Email ID: *****@caprabiosciences.com

Key Metrics

Founded Year

2020

Location

Manassas, United States

Stage

Series A

Total Funding

$5.75M in 4 rounds

Latest Funding Round

Series A, Nov 28, 2023, $*****

Investors

IndieBio & 8 more

Ranked

26^th among 152 active competitors

Employee Count

23 as on Apr 30, 2026

Similar Companies

Calyxia & 73 more

View Capra Biosciences' full profile

Capra Biosciences is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Capra Biosciences, Inc CIN: 844867474 , United States, Active	Dec 31, 2019	-	-	-

Capra Biosciences has raised a total funding of $5.75M over 4 rounds. Its first funding round was on Mar 17, 2021. Capra Biosciences has 9 institutional investors.

Here is the list of recent funding rounds of Capra Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 28, 2023	2389985	Series A	8724793	1912167	7906464	7852268
Jun 06, 2022	8776867	Seed	1622939	5983315	9566045	Prithvi Ventures & 6 more
Dec 20, 2021	8191996	Seed	9547763	9513136	2737839	7343880

Access funding benchmarks and valuations. Sign up today!

View details of Capra Biosciences's funding rounds and investors

The founders of Capra Biosciences is Andrew Magyar. Elizabeth Onderko is the CEO of Capra Biosciences.

Here are the details of Capra Biosciences' key team members:

Andrew Magyar: Co-Founder of Capra Biosciences.
Contact Info: 1 email address
Elizabeth Onderko: CEO of Capra Biosciences.
Contact Info: 1 email address

View details of Capra Biosciences's Founder profiles and Board Members

Capra Biosciences' employee count trend

Capra Biosciences has 23 employees as of Apr 26. Here is Capra Biosciences's employee count trend over the years:

Employee count trend for Capra Biosciences

Uncover Capra Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Capra Biosciences include LanzaTech, Manus Bio and Calyxia. Here is the list of Top 10 competitors of Capra Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	LanzaTech 2005, Skokie (United States), Public	Developer of technology converting carbon-rich gases into fuels and chemicals	$869M	Malaysian Life Sciences Capital Fund, British International Investment ... & 28 others	65/100
2nd	Manus Bio 2011, Cambridge (United States), Series B	Developer of phytochemicals using microbial fermentation	$125M	Nelstone Ventures, BBGI & 17 others	64/100
3rd	Calyxia 2011, Bonneuil sur Marne (France), Series B	Provider of diversified green chemicals	$53.7M	Lombard Odier, Astanor & 3 others	62/100
4th	Dioxycle 2021, Paris (France), Series A	Developer of technology converting carbon emissions into ethylene	$17M	Lowercarbon Capital, Breakthrough Energy & 5 others	58/100
5th	Bloom Biorenewables 2017, Fribourg (Switzerland), Series A	Developer of sustainable biopolymers from biomass	$19.7M	Yokogawa, Breakthrough Energy & 16 others	55/100
6th	OCO 2018, Oregon (United States), Seed	Manufacturer of green formic acid	$7.95M	TO VC, Bend Venture Conference & 9 others	52/100
7th	Equatic 2021, Los Angeles (United States), Series A	Developer of carbon dioxide removal technology producing hydrogen as a co-product	$17.8M	Catalytic Capital for Climate and Health, Kibo Invest ... Read more	51/100
8th	Co-reactive 2022, Aachen (Germany), Seed	Provider of tech solutions for correcting greenhouse gas emissions	$7.75M	HTGF, HBG Ventures & 6 others	51/100
9th	India Glycols 1983, Noida (India), Public	Provider of bulk, specialty and performance chemicals	-	BIRAC	51/100
10th	enaDyne 2022, Leipzig (Germany), Seed	Developer of plasma technology converting carbon dioxide into chemical resources	$8.23M	Energy Capital Ventures, Possible Ventures ... & 8 others	50/100
26th	Capra Biosciences 2020, Manassas (United States), Series A	Developer of bioreactor technology creating bio-based chemicals from waste materials	$5.75M	Groundswell Ventures, Prithvi Ventures & 7 others	45/100